Brief: Diaxonhit FY net loss declines to 5.5 mln euros
March 26 (Reuters) - Diaxonhit SA ALEHT.PA :
* Reports FY net loss of 5.5 million euros ($6.05 million)
versus loss of 6 million euros year ago
* 2014 sales of in-vitro diagnostic products reached 27.9
million euros, up 5.9 percent compared to 2013
Source text for Eikon: ID:nGNXVDCYRa
Further company coverage: ALEHT.PA
($1 = 0.9097 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million